Sacroiliitis, not elsewhere classified

M13_SACROILIITIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M46.1 Hospital discharge: ICD-9 — 7202 Hospital discharge: ICD-8 — 72699 Cause of death: ICD-10 — M46.1 Cause of death: ICD-9 — 7202 Cause of death: ICD-8 — 72699 2 out of 7 registries used, show all original rules.	2144
4. Check minimum number of events None	2144
5. Include endpoints None	2144
6. Filter based on genotype QC (FinnGen only)	2046

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M46
Name in latin: Sacroiliitis non alibi classificata

NAME	M13_SACROILIITIS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M461
HD_ICD_9	7202
HD_ICD_8	72699
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M461
COD_ICD_9	7202
COD_ICD_8	72699
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sacroiliitis, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11257	6845	4374
Only index persons	10866	6650	4216
Unadjusted period prevalence (%)
Whole population	0.17	0.20	0.12
Only index persons	0.21	0.24	0.16
Median age at first event (years)
Whole population	36.39	38.05	33.77
Only index persons	36.06	37.77	33.36

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2046	1422	624
Unadjusted period prevalence (%)	0.44	0.50	0.29
Median age at first event (years)	38.02	37.99	38.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2144: Matched controls
21440

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AB06

ATC

golimumab; parenteral

57.7

319.1

180

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

9.8

318.0

407

500

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

36.2

307.7

1310

892

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

32.2

307.7

334

122

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

188.4

307.7

505

M54.5

ICD-10 Finland

Low back pain

5.6

307.7

1144

3612

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

55.8

307.7

198

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

46.7

307.7

632

190

L04AB01

ATC

etanercept; parenteral

35.7

307.7

272

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

13.8

307.7

594

579

A07EC01

ATC

sulfasalazine; oral, rectal

59.8

307.7

1340

581

M45

ICD-10 Finland

Ankylosing spondylitis

1226.5

307.7

873

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

1050.3

307.7

423

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

47.1

307.7

537

151

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

32.0

307.7

397

151

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

14.9

307.7

342

270

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

25668.8

307.7

2049

M54.9

ICD-10 Finland

Dorsalgia, unspecified

9.2

307.7

536

748

L88

ICPC

Rheumatoid/seropositive arthritis

17.9

307.7

379

254

L04AB04

ATC

adalimumab; parenteral

26.9

307.7

383

172

M54.4

ICD-10 Finland

Lumbago with sciatica

7.5

307.7

556

955

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

44.7

307.7

640

202

L04AX03

ATC

methotrexate; systemic

12.6

307.7

747

875

M48.0

ICD-10 Finland

Spinal stenosis

30.3

259.6

173

M01AH05

ATC

etoricoxib; oral

5.7

256.0

1726

8979

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

12.0

239.3

254

238

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

20.4

233.9

182

M01AH01

ATC

celecoxib; oral

5.5

231.6

540

1230

N03AX12

ATC

[U] gabapentin; oral

6.5

227.4

425

787

N02AX02

ATC

tramadol; systemic, rectal

4.0

215.8

1015

3934

N03AX16

ATC

[U] pregabalin

5.1

215.4

558

1385

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

48.8

205.9

120

M01AC06

ATC

meloxicam; systemic, rectal

3.8

194.2

963

3812

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.9

186.1

273

388

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

24.7

179.4

128

L04AC10

ATC

secukinumab; parenteral

49.6

179.2

104

H02AB06

ATC

prednisolone; systemic

3.5

177.3

1235

5978

L01BA01

ATC

methotrexate; systemic

10.1

174.8

207

225

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

13.1

171.3

168

138

M47.82

ICD-10 Finland

Other spondylosis, cervical region

33.4

163.5

105

L04AB05

ATC

certolizumab pegol; parenteral

35.6

161.9

102

L03

ICPC

Low back symptom/complaint

3.5

157.8

781

3016

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

278.4

153.6

155

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

77.7

139.8

M13.9

ICD-10 Finland

Arthritis, unspecified

5.4

130.5

282

586

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

127.7

1065

5418

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

126.8

958

4618

M03BX02

ATC

tizanidine; oral

3.0

118.4

1516

9532

M25.5

ICD-10 Finland

Pain in joint

2.9

118.0

873

4127

A02BC02

ATC

pantoprazole; systemic

2.9

114.3

1491

9387

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

19.1

113.8

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

113.5

618

2459

M54.6

ICD-10 Finland

Pain in thoracic spine

5.2

109.6

246

526

M43.1

ICD-10 Finland

Spondylolisthesis

22.1

109.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

10.4

106.6

121

123

M54.3

ICD-10 Finland

Sciatica

8.5

103.7

137

170

N06AX21

ATC

duloxetine; oral

4.0

100.6

318

888

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

13.1

100.5

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

97.1

999

5443

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

21.2

92.9

UJF32

NOMESCO Finland

Coloscopy

2.9

89.1

524

2143

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

9.3

88.5

108

121

M54.1

ICD-10 Finland

Radiculopathy

13.2

86.6

H20.1

ICD-10 Finland

Chronic iridocyclitis

13.5

86.5

M70.6

ICD-10 Finland

Trochanteric bursitis

3.8

84.8

283

817

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

+∞

83.9

P01BA02

ATC

hydroxychloroquine; oral

4.1

83.2

252

679

M54.8

ICD-10 Finland

Other dorsalgia

6.4

82.7

141

232

M01AB05

ATC

diclofenac; systemic, rectal

2.5

82.3

1464

9949

M79.7

ICD-10 Finland

Fibromyalgia

6.7

79.3

129

202

M54

ICD-10 Finland

Dorsalgia

3.1

78.3

374

1353

L04AA13

ATC

[U] leflunomide

8.4

78.1

104

130

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

77.9

631

3010

M01AE02

ATC

naproxen; oral, rectal

2.4

77.4

1378

9254

M35.7

ICD-10 Finland

Hypermobility syndrome

10.6

76.0

A02BC03

ATC

lansoprazole; oral

2.6

75.9

568

2604

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

10.1

75.2

L86

ICPC

Back syndrome with radiating pain

5.6

74.4

146

275

N02BF01

ATC

gabapentin; oral

4.7

72.7

177

402

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

133.0

72.4

M01AH02

ATC

rofecoxib; oral

3.8

70.2

237

687

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

10.1

67.2

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

67.0

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

23.4

66.3

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.2

65.5

188

485

N06AA09

ATC

amitriptyline; systemic

4.1

64.3

187

487

A02BC05

ATC

esomeprazole; systemic

2.2

63.9

831

4791

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

10.5

63.7

M54.2

ICD-10 Finland

Cervicalgia

4.2

63.4

180

460

N02BE01

ATC

paracetamol; systemic, rectal

3.0

62.8

1893

15292

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

62.5

540

2618

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

58.8

871

5241

M47.9

ICD-10 Finland

Spondylosis, unspecified

94.3

58.2

M79.6

ICD-10 Finland

Pain in limb

2.1

56.8

878

5352

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

16.3

56.5

H02AB07

ATC

prednisone; oral

2.9

56.3

307

1184

A07EC02

ATC

mesalazine; oral, rectal

3.8

55.8

184

523

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

7.4

55.7

115

72699

ICD-8 Finland

Affection of sacro-iliac joint

+∞

55.4

S01FA04

ATC

cyclopentolate; ophthalmic

12.0

54.2

WZA10

NOMESCO Finland

Extensive medical or dental certificate

9.2

53.9

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

53.5

521

2639

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

+∞

53.3

A07EA06

ATC

budesonide; oral, local oral

4.5

52.9

133

309

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

52.2

596

3217

M01AX17

ATC

nimesulide; oral

2.5

51.5

400

1832

S01BA04

ATC

prednisolone; ophthalmic

7.6

51.5

101

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

7.6

50.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

49.9

452

2214

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

6.3

49.6

140

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

8.1

49.6

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

49.3

251

930

7202A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Sacro-iliitis, not elsewhere classified

+∞

49.1

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.5

49.0

180

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

63.8

48.5

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.8

48.0

266

1031

M46.0

ICD-10 Finland

Spinal enthesopathy

478.1

47.5

M50.3

ICD-10 Finland

Other cervical disc degeneration

18.4

47.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

46.5

660

3841

TNG10

NOMESCO Finland

Puncture of knee

9.5

46.4

S01BA01

ATC

dexamethasone; ophthalmic

4.9

46.3

104

220

N02BF02

ATC

pregabalin; oral

4.2

46.2

127

316

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

46.1

462

2352

N02AA05

ATC

oxycodone; systemic

2.9

45.7

238

891

NF1AA

NOMESCO Finland

Hip X-ray examination

4.0

45.5

136

360

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

45.5

660

3866

S01FA02

ATC

scopolamine; ophthalmic

16.8

45.4

R4110

NOMESCO Finland

Physiotherapy

2.1

45.3

521

2798

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

44.9

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.8

44.7

108

A01

ICPC

Pain general/multiple sites

3.2

43.9

189

635

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.7

42.9

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.6

42.8

105

239

M01AX01

ATC

nabumetone; oral

5.2

42.6

177

J01AA02

ATC

doxycycline; systemic

2.0

42.2

1537

12069

K50.0

ICD-10 Finland

Crohn disease of small intestine

6.4

42.1

115

M01AH03

ATC

valdecoxib; oral

3.9

41.9

126

335

L04AX01

ATC

azathioprine; systemic

3.7

41.7

137

387

ZX120

NOMESCO Finland

Intravenous

2.9

41.7

210

771

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

41.6

938

6318

L84

ICPC

Back syndrome without radiat pain

4.0

41.6

121

314

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.0

40.9

200

722

H57.1

ICD-10 Finland

Ocular pain

3.8

40.8

129

355

A02BC01

ATC

omeprazole; systemic

2.1

40.7

495

2702

K50.9

ICD-10 Finland

Crohn disease, unspecified

6.4

40.4

110

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

12.3

40.2

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

8.1

40.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

40.0

156

493

H02AB04

ATC

methylprednisolone; systemic

2.5

39.5

287

1266

R51.80

ICD-10 Finland

Headache

2.2

38.6

384

1937

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.1

38.0

107

271

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.7

37.6

214

837

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

37.6

4AB02, ,

NOMESCO Finland

13.8

36.6

Z3226

NOMESCO Finland

Physiotherapist

2.2

35.7

338

1668

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

35.4

580

3492

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.9

35.4

108

290

L02

ICPC

Back symptom/complaint

2.5

35.1

243

1046

R06.0

ICD-10 Finland

Dyspnoea

2.0

35.0

441

2424

A02BA02

ATC

ranitidine; systemic

2.3

34.5

303

1448

N02AJ13

ATC

tramadol and paracetamol; systemic

7.1

34.4

M01AB55

ATC

diclofenac, combinations; oral

3.9

34.3

104

278

K50.8

ICD-10 Finland

Other Crohn disease

5.6

34.0

119

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

33.8

254

1134

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

7.5

33.6

R52.9

ICD-10 Finland

Pain, unspecified

2.6

32.9

201

814

G44.2

ICD-10 Finland

Tension-type headache

2.2

32.5

308

1516

R50.9

ICD-10 Finland

Fever, unspecified

2.2

32.4

322

1615

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

32.3

701

4581

J01MA02

ATC

ciprofloxacin; systemic

1.8

32.1

673

4352

UJF92

NOMESCO Finland

Capsular endoscopy

5.0

31.7

142

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

8.2

31.7

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

9.0

31.6

R52.2

ICD-10 Finland

Other chronic pain

4.5

31.5

179

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

31.4

163

607

M02AA07

ATC

piroxicam; topical

1.8

31.3

562

3462

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.2

30.9

207

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.3

30.9

122

388

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.1

30.5

345

1817

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

30.5

821

5684

L40.5

ICD-10 Finland

Arthropathic psoriasis

5.9

30.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

30.2

730

4900

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.4

30.0

113

349

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.1

29.9

126

SPAT1153

SPAT

Removal of sutures

1.9

29.8

507

3066

R03AC02

ATC

salbutamol; inhalant

1.7

29.7

1150

8747

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

35.1

29.7

L28

ICPC

Limited function/disability (L)

2.4

29.4

227

1024

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.5

29.3

196

828

M01AB08

ATC

etodolac; oral

2.9

29.3

140

498

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

28.7

252

1199

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.5

28.2

161

J01DB01

ATC

cefalexin; oral

1.9

28.1

1742

14955

L13

ICPC

Hip symptom/complaint

2.2

28.0

269

1327

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

7.5

28.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

27.3

269

1340

R42

ICD-10 Finland

Dizziness and giddiness

2.0

27.2

365

2037

M79.1

ICD-10 Finland

Myalgia

2.0

27.0

322

1723

S18

ICPC

Laceration/cut

1.7

26.9

755

5242

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

26.8

423

2487

XA402

NOMESCO Finland

ENMG

6.2

26.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.5

26.7

268

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

26.6

231

1094

L99

ICPC

Musculoskeletal disease other

5.0

26.6

116

N06AX16

ATC

venlafaxine; oral

2.0

26.4

320

1721

H15.1

ICD-10 Finland

Episcleritis

5.2

26.4

109

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

7.7

26.4

H20

ICD-10 Finland

Iridocyclitis

8.8

26.3

WZC30

NOMESCO Finland

Teaching

2.1

26.3

281

1444

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

8.2

25.7

M02AA10

ATC

ketoprofen; topical

2.1

25.6

259

1303

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

25.5

343

1911

N06AX11

ATC

mirtazapine; oral

1.7

25.5

638

4283

M01AB01

ATC

indometacin; systemic, rectal

3.3

25.4

302

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

25.4

166

693

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

25.2

1599

13530

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

25.0

J01FA10

ATC

azithromycin; systemic

1.6

25.0

1297

10418

SPAT1263

SPAT

Sampling

1.6

24.8

839

6076

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

91.2

24.7

E0000UV, ,

ATC

1.6

24.4

872

6392

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

24.4

222

1071

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.6

24.3

L01

ICPC

Neck symptom/complaint

2.0

24.0

311

1710

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

23.9

150

614

P01AB01

ATC

metronidazole; oral, rectal

1.6

23.7

790

5685

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

8.7

23.7

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.8

23.7

125

469

J01FF01

ATC

clindamycin; systemic

1.7

23.7

502

3212

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

23.5

167

724

SPAT1260

SPAT

Consultation of another employee

1.9

23.4

320

1789

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.9

23.4

113

404

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

23.3

405

2445

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

5.0

23.3

102

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

23.2

1538

12993

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

23.1

1530

12912

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

23.1

228

1135

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

23.0

418

2556

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

22.9

159

682

Z01.2

ICD-10 Finland

Dental examination

1.6

22.8

1004

7692

J01FA06

ATC

roxithromycin; oral

1.6

22.8

735

5235

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

22.7

419

2574

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

22.5

1238

9966

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.6

22.5

214

L04AB02

ATC

infliximab; parenteral

7.3

22.5

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

6.2

22.4

G54.0

ICD-10 Finland

Brachial plexus disorders

4.3

22.3

134

SPAT1301

SPAT

No procedures

1.7

22.2

539

3570

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

22.1

487

3141

ZX140

NOMESCO Finland

Intra articular

7.7

22.1

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

29.4

21.9

K02.1

ICD-10 Finland

Caries of dentine

1.6

21.9

1328

10902

R01AD09

ATC

mometasone; nasal

1.6

21.8

987

7583

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

20.3

21.7

L17

ICPC

Foot/toe symptom/complaint

1.7

21.6

499

3256

SFA20

NOMESCO Finland

Two-surface restoration

1.6

21.6

1274

10377

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

21.5

349

2058

D07AC01

ATC

betamethasone; topical

1.6

21.5

662

4647

SFA10

NOMESCO Finland

One-surface restoration

1.6

21.4

1190

9555

N02AC04

ATC

dextropropoxyphene; oral

5.4

21.4

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

21.3

718

5147

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

7.9

21.3

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.7

21.3

106

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.2

21.1

J01CA04

ATC

amoxicillin; systemic

1.8

21.1

1789

15864

K07.60

ICD-10 Finland

Snapping jaw

2.5

21.0

140

589

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.3

21.0

174

807

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

20.9

586

4016

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

20.9

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

24.5

20.9

M43.0

ICD-10 Finland

Spondylolysis

24.5

20.9

R06AE07

ATC

cetirizine; oral

1.5

20.8

947

7259

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.9

20.8

275

1519

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

20.7

341

M01AC01

ATC

piroxicam; systemic, rectal

2.2

20.6

190

919

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

20.6

335

1977

R01AD08

ATC

fluticasone; nasal

1.6

20.5

614

4272

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

20.4

234

1229

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.7

20.4

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

20.3

1142

9146

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.0

20.2

M53.2

ICD-10 Finland

Spinal instabilities

48.5

20.2

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.9

20.1

150

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.9

20.0

331

SPAT1310

SPAT

Counselling related to known health issue

1.6

20.0

595

4129

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

19.8

390

2430

R02

ICPC

Shortness of breath/dyspnoea

2.1

19.7

200

1005

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

19.6

19.5

Z50.1

ICD-10 Finland

Other physical therapy

3.0

19.5

287

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.2

19.4

127

K30

ICD-10 Finland

Functional dyspepsia

2.0

19.3

217

1131

AA1AD

NOMESCO Finland

CT of head and brain

1.8

19.3

344

2083

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

31.6

19.3

R07.3

ICD-10 Finland

Other chest pain

2.2

19.2

164

770

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

19.0

128

541

M01CB01

ATC

sodium aurothiomalate; parenteral

6.2

18.9

D07AD01

ATC

clobetasol; topical

1.8

18.9

299

1746

ACC51

NOMESCO Finland

Release of median nerve

2.4

18.9

132

568

Z71.8

ICD-10 Finland

Other specified counselling

1.6

18.8

648

4643

R01AD58

ATC

fluticasone, combinations; nasal

1.6

18.8

587

4112

M25.2

ICD-10 Finland

Flail joint

5.4

18.7

K51.5

ICD-10 Finland

Left sided colitis

3.0

18.6

284

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

6.1

18.6

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

5.1

18.6

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

5.1

18.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

18.4

978

7683

R52.1

ICD-10 Finland

Chronic intractable pain

17.7

18.2

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

18.2

705

5176

L04AC13

ATC

ixekizumab; parenteral

21.9

18.2

L15

ICPC

Knee symptom/complaint

1.7

18.1

397

2544

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

18.1

127

548

XX9XE

NOMESCO Finland

Other ultrasound examination

6.3

18.0

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

4.6

18.0

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

18.0

319

1926

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

18.0

114

469

M13.8

ICD-10 Finland

Other specified arthritis

5.9

17.9

J01DA01

ATC

[U] cefalexin

1.5

17.9

1204

9899

NA3BG, ,

SPAT

2.9

17.9

296

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

17.9

1081

8698

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

17.8

532

3679

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

17.8

169

827

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

17.7

1943

17863

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

67.2

17.7

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

17.7

L20

ICPC

Joint symptom/complaint NOS

3.0

17.7

265

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

17.7

314

1896

NA6BG, ,

SPAT

14.7

17.6

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

95.9

17.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

17.5

117

493

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

17.4

374

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

29.0

17.4

R01AD12

ATC

fluticasone furoate; nasal

1.5

17.3

724

5395

J02AC01

ATC

fluconazole; systemic

1.5

17.1

825

6323

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.4

17.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

17.0

245

1387

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

17.0

457

3078

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

7.2

17.0

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

16.9

351

2213

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

16.9

138

636

N03AE01

ATC

clonazepam; systemic

2.6

16.8

387

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

16.8

100

399

J20

ICD-10 Finland

Acute bronchitis

2.0

16.8

188

978

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

16.8

139

644

N05CF01

ATC

zopiclone; oral

1.6

16.7

481

3292

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

16.7

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.0

16.7

242

C07AA05

ATC

propranolol; systemic

1.6

16.6

427

2843

M46

ICD-10 Finland

Other inflammatory spondylopathies

90.8

16.6

J01FA09

ATC

clarithromycin; systemic

1.5

16.6

610

4413

L08

ICPC

Shoulder symptom/complaint

1.7

16.6

340

2136

RF120, ,

NOMESCO Finland

7.0

16.5

N04BC05

ATC

pramipexole; oral

2.5

16.2

102

418

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

16.2

177

912

F01

ICPC

Eye pain

3.1

16.2

225

N06AB04

ATC

citalopram; systemic

1.7

16.2

360

2310

R5599

NOMESCO Finland

Other rehabilitation service

3.8

16.0

132

K92.1

ICD-10 Finland

Melaena

3.0

15.7

245

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

15.8

15.7

R09

ICPC

Sinus symptom/complaint

1.9

15.7

194

1044

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.9

15.7

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

15.6

D07XC01

ATC

betamethasone; topical

1.9

15.6

206

1134

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

85.7

15.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

15.5

105

445

M46.4

ICD-10 Finland

Discitis, unspecified

161.1

15.5

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

6.3

15.5

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

38.3

15.4

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

6.5

15.4

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.2

15.3

130

608

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

15.3

156

784

A07EA02

ATC

hydrocortisone; rectal

3.4

15.2

161

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.1

233

1347

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

15.1

238

1385

J04AB02

ATC

rifampicin; systemic

5.8

14.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

14.9

172

904

R53

ICD-10 Finland

Malaise and fatigue

1.6

14.9

439

3013

M07.3

ICD-10 Finland

Other psoriatic arthropathies

5.2

14.9

J01MA12

ATC

levofloxacin; systemic

1.8

14.8

256

1530

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

6.0

14.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.0

14.8

ZXA05

NOMESCO Finland

Left side

1.7

14.8

324

2067

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

14.8

197

1087

K51.8

ICD-10 Finland

Other ulcerative colitis

3.9

14.7

108

R60.0

ICD-10 Finland

Localized oedema

2.0

14.7

154

782

9211

FHL

Exploration or removal of diskusprolapse

+∞

14.6

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

14.6

M01AE51

ATC

ibuprofen, combinations; systemic

6.6

14.5

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

151.0

14.5

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

14.4

151

766

G47.3

ICD-10 Finland

Sleep apnoea

1.6

14.4

345

2251

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

14.4

230

R03DC03

ATC

montelukast; oral

1.7

14.3

316

2020

H02BX01

ATC

methylprednisolone, combinations; systemic

3.1

14.3

199

A03

ICPC

Fever

1.6

14.2

395

2670

N05AH04

ATC

quetiapine; oral

1.6

14.2

355

2341

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

14.2

282

1753

L01BB02

ATC

mercaptopurine; oral

3.7

14.1

125

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.4

14.1

390

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

5.0

14.1

A02BC04

ATC

rabeprazole; oral

2.0

14.0

164

866

M01AE52

ATC

naproxen and esomeprazole; oral

3.1

14.0

196

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

14.0

108

486

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

13.9

308

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

30.2

13.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.6

13.8

SPAT1104

SPAT

Monitoring of emergency patient

2.3

13.8

102

450

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

13.8

1219

10322

M41.9

ICD-10 Finland

Scoliosis, unspecified

10.5

13.7

R03BA01

ATC

beclometasone; inhalant

1.8

13.7

228

1347

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

13.7

258

1579

R05

ICPC

Cough

1.5

13.7

431

2997

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.1

13.6

178

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

75.6

13.6

XCK00

NOMESCO Finland

Perimetry

2.6

13.6

324

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.9

13.5

101

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

13.5

331

2169

WX290

NOMESCO Finland

Other blockage of nerve

1.4

13.5

1078

8951

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

13.5

196

1112

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

140.9

13.5

N05CF02

ATC

zolpidem; oral

1.7

13.4

302

1937

R11

ICD-10 Finland

Nausea and vomiting

2.0

13.4

158

836

A01AB09

ATC

miconazole; local oral

2.1

13.4

137

689

L04AA11

ATC

[U] etanercept

12.9

13.4

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

18.3

13.4

C10AC01

ATC

colestyramine; oral

3.2

13.3

160

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.4

13.3

145

M77.4

ICD-10 Finland

Metatarsalgia

2.1

13.3

120

576

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.6

13.3

121

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

13.2

704

5434

R74

ICPC

Upper respiratory infection acute

1.4

13.2

765

5997

N05BA04

ATC

oxazepam; oral

1.5

13.2

441

3104

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

13.1

381

2597

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

13.1

398

2742

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

13.1

112

526

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

13.1

167

908

D01

ICPC

Abdominal pain/cramps general

1.7

13.1

237

1435

WX002

NOMESCO Finland

Sedation and analgesia

1.7

13.0

275

1734

R06AX27

ATC

desloratadine; oral

1.5

13.0

636

4828

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

13.0

416

2899

-1, ,

NOMESCO Finland

1.4

12.9

717

5570

RF410, ,

NOMESCO Finland

5.6

12.9

B01AB05

ATC

enoxaparin; parenteral

1.5

12.9

439

3100

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.5

12.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

12.8

398

2753

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.6

12.8

280

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.1

12.8

X58

ICD-10 Finland

Exposure to other specified factors

1.7

12.7

264

1657

EB1VA, ,

NOMESCO Finland

1.7

12.7

239

1461

UKC02

NOMESCO Finland

Cystoscopy

1.9

12.6

157

846

R51

ICD-10 Finland

Headache

2.1

12.6

126

629

R25.2

ICD-10 Finland

Cramp and spasm

3.6

12.6

116

A07DA03

ATC

loperamide; oral

3.2

12.5

161

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

12.5

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

12.5

496

3612

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

12.5

102

470

S01ED51

ATC

timolol, combinations; ophthalmic

2.4

12.5

362

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.8

12.5

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.8

12.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

12.5

136

701

Z00.0

ICD-10 Finland

General medical examination

1.6

12.5

333

2226

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.9

12.4

210

D02

ICPC

Abdominal pain epigastric

2.1

12.4

115

558

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

12.4

161

881

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

12.3

268

S01EC01

ATC

acetazolamide; systemic

3.6

12.3

113

XQ800

NOMESCO Finland

Prick test

1.9

12.2

167

928

NA3CG, ,

SPAT

4.3

12.2

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.8

12.2

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

12.2

352

2395

NG1DA

NOMESCO Finland

X-ray of knees

5.0

12.2

J35.0

ICD-10 Finland

Chronic tonsillitis

1.9

12.1

154

836

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

26.8

12.0

R51.81

ICD-10 Finland

Facial pain NOS

3.1

12.0

160

R00.2

ICD-10 Finland

Palpitations

1.9

12.0

157

861

M02.8

ICD-10 Finland

Other reactive arthropathies

9.3

12.0

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.9

11.9

NA6CF

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with median intensity magnet

46.9

11.9

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.9

11.8

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

11.8

310

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

4.5

11.7

NBG10

NOMESCO Finland

Acromioplastia

4.5

11.7

SPAT1097

SPAT

Recording of ECG

1.8

11.7

181

1047

ZXA00

NOMESCO Finland

Right side

1.6

11.7

338

2300

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

11.6

811

6531

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.1

11.6

153

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

11.6

279

1818

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

11.6

204

1225

M03BX01

ATC

baclofen; systemic

3.7

11.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

11.5

176

1014

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

4.0

11.5

G50.1

ICD-10 Finland

Atypical facial pain

3.8

11.5

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

11.5

M01AE11

ATC

tiaprofenic acid; oral, rectal

3.1

11.5

154

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

120.6

11.4

4AB0M, ,

NOMESCO Finland

120.6

11.4

S01ED01

ATC

timolol; ophthalmic

3.1

11.4

149

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.7

11.4

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.7

11.4

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.2

11.4

139

R03AC03

ATC

terbutaline; inhalant

1.6

11.3

251

1601

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

11.3

168

960

M05BA04

ATC

alendronic acid; oral

2.2

11.3

418

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

35.2

11.3

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

4.8

11.2

L12

ICPC

Hand/finger symptom/complaint

1.6

11.2

285

1882

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

11.2

146

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

11.2

115

581

S06.0

ICD-10 Finland

Concussion

1.8

11.2

183

1076

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

11.0

115

583

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

10.1

11.0

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.7

11.0

A07AA02

ATC

nystatin; oral

2.3

10.9

340

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

43.5

10.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

10.9

101

490

D06

ICPC

Abdominal pain localized other

1.8

10.9

162

925

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.1

10.9

101

491

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.9

10.8

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.9

10.8

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

10.8

112

567

UJD02

NOMESCO Finland

Gastroscopy

2.6

10.8

250

JAH01

NOMESCO Finland

Laparoscopy

2.2

10.8

393

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

10.7

148

826

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

10.7

216

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

10.7

312

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

10.6

117

605

R06AX22

ATC

ebastine; oral

1.5

10.6

340

2361

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

60.3

10.6

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.4

10.6

313

N06AA10

ATC

nortriptyline; systemic

3.5

10.6

100

SPAT1325

SPAT

Vaccination

1.4

10.6

501

3759

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.3

10.5

120

Z3231

NOMESCO Finland

Registered nurse

1.5

10.5

422

3067

SPAT1229

SPAT

Assessment of need for aid

2.3

10.5

352

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

10.5

352

WW200

NOMESCO Finland

Immunization

2.6

10.4

219

ZXA10

NOMESCO Finland

Bilateral

1.6

10.4

255

1666

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

110.6

10.4

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

+∞

10.4

SPAT1210

SPAT

Application of cast or individual aid

2.4

10.4

285

D82

ICPC

Teeth/gum disease

1.4

10.4

800

6512

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.7

10.3

197

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

12.1

10.3

J01DA09

ATC

[U] cefadroxil

1.4

10.3

485

3632

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

10.3

147

829

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

10.3

158

911

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

10.3

139

771

D05AX52

ATC

calcipotriol, combinations; topical

2.2

10.3

428

RF420, ,

NOMESCO Finland

4.7

10.2

G03DB01

ATC

dydrogesterone; oral

1.6

10.2

260

1714

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

10.2

205

1274

L18

ICPC

Muscle pain

2.4

10.2

306

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

10.2

344

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.6

10.2

SPAT1216

SPAT

Assessment of functional ability

1.8

10.1

160

930

L04AC05

ATC

ustekinumab; parenteral

7.9

10.1

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.6

10.1

J45

ICD-10 Finland

Asthma

1.7

10.0

179

1078

J01EA01

ATC

trimethoprim; systemic

1.4

10.0

429

3157

RF421, ,

NOMESCO Finland

14.6

10.0

N05BA01

ATC

diazepam; systemic, rectal

1.7

10.0

187

1141

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

10.0

254

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

10.0

107

549

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

40.3

10.0

M75.5

ICD-10 Finland

Bursitis of shoulder

3.1

9.9

135

A03FA02

ATC

cisapride; oral, rectal

2.1

9.9

427

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

9.9

456

3401

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

9.8

1445

12925

C07AB07

ATC

bisoprolol; oral

1.4

9.8

548

4225

R10.0

ICD-10 Finland

Acute abdomen

2.5

9.8

250

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

20.1

9.8

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

10.7

9.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

9.8

302

2080

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

9.6

9.8

M76.6

ICD-10 Finland

Achilles tendinitis

2.4

9.7

294

L16

ICPC

Ankle symptom/complaint

1.7

9.7

200

1251

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

9.7

218

1395

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

9.7

378

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

9.7

116

619

R04.0

ICD-10 Finland

Epistaxis

2.1

9.7

425

TNF10

NOMESCO Finland

Puncture of hip joint

55.2

9.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

9.6

123

670

K08.80

ICD-10 Finland

Toothache NOS

1.7

9.6

182

1115

SPAT1283

SPAT

Restricted health certificate

1.4

9.5

456

3421

J01FA01

ATC

erythromycin; systemic

1.5

9.5

309

2150

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

9.5

166

WW200, ,

SPAT

1.5

9.5

370

2672

G03DC02

ATC

norethisterone; oral

1.8

9.4

155

912

R03AC13

ATC

formoterol; inhalant

2.3

9.4

324

NF1DA

NOMESCO Finland

X-ray of hips

3.9

9.4

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

9.4

167

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

9.4

363

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

30.2

9.4

SFA30

NOMESCO Finland

Three-surface restoration

1.4

9.4

732

5948

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

9.3

397

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.2

9.3

114

M01AX05

ATC

glucosamine; oral

1.7

9.3

170

1030

ZYC01, ,

SPAT

1.6

9.3

198

1249

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

9.3

288

1984

H30.2

ICD-10 Finland

Posterior cyclitis

9.5

9.3

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.1

9.2

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.1

9.2

R03BA05

ATC

fluticasone; inhalant

1.5

9.2

321

2265

C01CA24

ATC

epinephrine; parenteral

1.8

9.1

138

792

N06AB10

ATC

escitalopram; oral

1.4

9.1

428

3196

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

9.1

394

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

9.1

179

1106

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

9.1

603

4775

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

4.6

9.1

M02.1

ICD-10 Finland

Postdysenteric arthropathy

11.5

9.1

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

9.1

107

568

N83.1

ICD-10 Finland

Corpus luteum cyst

3.2

9.0

106

A02BA04

ATC

nizatidine; systemic

2.2

9.0

369

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

9.0

145

848

M50.8

ICD-10 Finland

Other cervical disc disorders

36.8

9.0

D11

ICPC

Diarrhoea

1.6

9.0

247

1656

S01EA05

ATC

brimonidine; ophthalmic

3.7

9.0

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

9.0

122

A06AD11

ATC

lactulose; oral

1.8

8.9

145

850

M01AC02

ATC

tenoxicam; systemic, rectal

2.6

8.9

195

H26.3

ICD-10 Finland

Drug-induced cataract

7.5

8.9

SPAT1312

SPAT

General health counselling

1.4

8.9

591

4675

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

8.9

740

6059

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.0

8.9

467

SGA01

NOMESCO Finland

Emergency treatment

1.5

8.9

343

2471

R21

ICPC

Throat symptom/complaint

1.4

8.8

501

3864

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

8.8

533

4158

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

8.7

296

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

14.1

8.7

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

50.2

8.7

H81.0

ICD-10 Finland

Ménière disease

3.2

8.7

109

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

8.6

182

1146

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

8.6

143

844

C09CA06

ATC

candesartan; oral

1.5

8.6

343

2484

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

8.6

220

1452

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

8.6

154

929

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

8.6

139

815

H02AB09

ATC

hydrocortisone; systemic

2.7

8.6

170

R4120

NOMESCO Finland

Occupational therapy

1.9

8.6

515

N06AX12

ATC

bupropion; oral

1.7

8.5

164

1008

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

8.5

224

M01AB16

ATC

aceclofenac; oral

2.9

8.5

137

M75.8

ICD-10 Finland

Other shoulder lesions

2.2

8.5

319

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

27.6

8.5

N06AX03

ATC

mianserin; oral

2.3

8.5

268

K29.1

ICD-10 Finland

Other acute gastritis

4.2

8.5

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

8.4

215

1417

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

8.4

133

774

M48.9

ICD-10 Finland

Spondylopathy, unspecified

90.4

8.4

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

90.4

8.4

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.9

8.4

127

D07AC13

ATC

mometasone; topical

1.4

8.4

486

3757

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

8.4

111

612

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

8.4

145

866

C03CA01

ATC

furosemide; systemic

1.6

8.4

228

1526

NA6AG, ,

NOMESCO Finland

+∞

8.3

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

8.3

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

8.3

106

578

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

8.3

139

823

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

8.3

154

938

G04BD08

ATC

solifenacin; oral

2.2

8.3

309

S01BC03

ATC

diclofenac; ophthalmic

2.8

8.3

139

R12

ICD-10 Finland

Heartburn

1.8

8.3

133

778

OAA65, ,

SPAT

1.4

8.3

416

3140

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

8.2

323

C08CA05

ATC

nifedipine; systemic

2.1

8.2

343

C05AA08

ATC

fluocortolone; rectal, topical

1.6

8.2

188

1210

A05

ICPC

Feeling ill

1.8

8.2

132

774

M13.0

ICD-10 Finland

Polyarthritis, unspecified

3.6

8.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

8.1

160

990

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

8.1

370

2745

SPAT1240

SPAT

Therapeutic discussion

1.5

8.1

237

1611

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

8.1

550

4357

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.2

8.1

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

8.1

199

M17.5

ICD-10 Finland

Other secondary gonarthrosis

3.8

8.1

H20.8

ICD-10 Finland

Other iridocyclitis

6.8

8.1

RK220, ,

NOMESCO Finland

8.9

8.0

TAB20

NOMESCO Finland

Epidural puncture

10.1

8.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

8.0

140

840

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.3

8.0

269

R2110

NOMESCO Finland

Giving the first information

1.7

7.9

134

795

RF210, ,

NOMESCO Finland

2.6

7.9

177

L11

ICPC

Wrist symptom/complaint

1.6

7.9

166

1044

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

7.9

245

1687

WZC30, ,

SPAT

2.1

7.9

376

256, ,

Kela drug reimbursment

13.1

7.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

7.9

383

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.5

7.8

196

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

7.8

377

G72.9

ICD-10 Finland

Myopathy, unspecified

8.5

7.8

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.4

7.8

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

7.8

304

SPAT1058

SPAT

PEF monitoring instruction

1.8

7.8

108

605

XKD00

NOMESCO Finland

Uroflowmetry

1.8

7.8

113

642

N03AX09

ATC

lamotrigine; oral

1.8

7.8

104

576

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.4

7.8

203

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

7.7

448

R52.0

ICD-10 Finland

Acute pain

2.2

7.7

292

M85.3

ICD-10 Finland

Osteitis condensans

45.1

7.7

WZC00, ,

SPAT

1.6

7.7

176

1131

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

7.7

125

734

N05BA12

ATC

alprazolam; oral

1.7

7.7

151

934

N06AB03

ATC

fluoxetine; oral

1.6

7.7

201

1333

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

7.7

254

M19.8

ICD-10 Finland

Other specified arthrosis

2.5

7.7

186

M05BA07

ATC

risedronic acid; oral

3.3

7.7

R31

ICD-10 Finland

Unspecified haematuria

1.9

7.7

521

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

7.6

340

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.7

7.6

J05AB01

ATC

aciclovir; systemic

1.4

7.6

369

2765

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

7.6

131

782

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

7.6

515

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

7.6

153

953

B02AA02

ATC

tranexamic acid; systemic

1.5

7.5

269

1905

XPX04

NOMESCO Finland

Angioscopy

8.9

7.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

7.5

178

1153

298, ,

Kela drug reimbursment

10.1

7.5

R4110, ,

SPAT

1.8

7.5

109

619

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.0

7.5

377

SPAT1211

SPAT

Application of soft bandage

1.7

7.5

125

741

R07.0

ICD-10 Finland

Pain in throat

1.7

7.4

144

888

H01

ICPC

Ear pain/earache

1.5

7.4

216

1467

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

80.4

7.4

U07

ICPC

Urine symptom/complaint other

1.9

7.4

505

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

7.4

214

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.6

7.4

154

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

7.4

463

XQ802

NOMESCO Finland

Epicutan test

1.9

7.4

435

M22.4

ICD-10 Finland

Chondromalacia patellae

2.2

7.3

292

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

8.4

7.3

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.3

375

2836

ACC53

NOMESCO Finland

Release of ulnar nerve

3.6

7.3

NA6DG

NOMESCO Finland

Sacro-iliac joint very extensive MRI examination with high intensity magnet

+∞

7.3

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

7.3

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

7.3

203

KMAK, ,

NOMESCO Finland

1.3

7.3

1058

9263

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.1

7.3

313

M19.2

ICD-10 Finland

Other secondary arthrosis

3.8

7.3

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

7.2

156

988

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

7.2

114

664

WX704

NOMESCO Finland

Intubation

1.8

7.2

114

665

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

7.2

421

3252

C08CA01

ATC

amlodipine; oral

1.4

7.2

387

2950

K64.0

ICD-10 Finland

First degree haemorrhoids

2.5

7.2

174

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.9

7.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

7.2

105

599

A06AC51

ATC

ispaghula, combinations; oral

2.1

7.2

342

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

30.1

7.1

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

20.1

7.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

7.1

170

1104

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

7.1

336

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

12.1

7.1

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.1

7.1

OAA81, ,

SPAT

2.0

7.1

364

K50

ICD-10 Finland

Crohn disease [regional enteritis]

6.0

7.1

OAB93, ,

SPAT

1.7

7.1

138

853

3029

Kela drug reimbursment

Upadacitinib

8.8

7.0

K80

ICPC

Cardiac arrhythmia NOS

1.8

7.0

102

580

-50

ICPC

Medication/prescr/renewal

2.2

7.0

258

L04

ICPC

Chest symptom/complaint

1.8

7.0

544

R01AD11

ATC

triamcinolone; nasal

1.6

7.0

147

926

SPAT1254

SPAT

Administration of medicine

1.5

7.0

197

1329

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

7.0

546

4405

R83

ICPC

Respiratory infection other

1.3

6.9

605

4952

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.5

6.9

171

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

5.5

6.9

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

6.9

221

35399

ICD-8 Finland

Sciatica

13.8

6.9

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

6.9

209

W19

ICD-10 Finland

Unspecified fall

1.7

6.9

132

813

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

6.8

341

TAB00

NOMESCO Finland

Lumbar puncture

2.0

6.8

362

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.3

6.8

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.9

6.8

109

A04AA01

ATC

ondansetron; systemic, rectal

1.7

6.8

114

677

G04CA02

ATC

tamsulosin; oral

1.6

6.8

141

886

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

6.8

104

602

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

40.2

6.8

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

40.2

6.8

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.8

464

3670

EMB10

NOMESCO Finland

Tonsillectomy

1.6

6.8

147

934

G03CA04

ATC

estriol; systemic, vaginal

2.2

6.8

262

J01FA15

ATC

telithromycin; oral

1.6

6.7

154

990

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

6.7

492

63497

ICD-8 Finland

Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis

3.2

6.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

6.7

218

1515

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.9

6.7

ZY010, ,

SPAT

3.4

6.7

J01

ICD-10 Finland

Acute sinusitis

1.7

6.7

110

649

M41.2

ICD-10 Finland

Other idiopathic scoliosis

22.6

6.7

R13

ICD-10 Finland

Dysphagia

1.9

6.7

436

SPAT1255

SPAT

Intravenous administration of medicine

1.9

6.6

465

F29

ICPC

Eye symptom/complaint other

1.6

6.6

152

978

P76

ICPC

Depressive disorder

1.6

6.6

135

844

H15.0

ICD-10 Finland

Scleritis

7.8

6.6

SPAT1202

SPAT

Intra-articular injection

2.9

6.6

100

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

12.3

6.6

R19

ICD-10 Finland

Other symptoms and signs involving the digestive system and abdomen

12.3

6.6

B01AB10

ATC

tinzaparin; parenteral

1.6

6.6

131

815

J01MA06

ATC

norfloxacin; oral

1.5

6.6

187

1265

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

8.7

6.5

D94

ICPC

Chronic enteritis/ulcerative colitis

3.8

6.5

NH3AE

NOMESCO Finland

Feet ultrasound examination

10.0

6.5

R03AC12

ATC

salmeterol; inhalant

2.2

6.5

246

M03AX01

ATC

botulinum toxin; parenteral

2.7

6.5

123

M53.9

ICD-10 Finland

Dorsopathy, unspecified

6.9

6.5

E000001, ,

ATC

1.4

6.5

363

2781

Z2446

NOMESCO Finland

Social worker

1.7

6.4

104

611

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

6.4

191

1303

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

70.1

6.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

6.4

159

1043

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

6.4

567

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

6.4

136

L95

ICPC

Osteoporosis

2.6

6.4

136

N05AH02

ATC

clozapine; systemic

0.1

6.4

238

D19

ICPC

Teeth/gum symptom/complaint

1.3

6.4

541

4405

NB1BG, ,

SPAT

2.3

6.3

210

SPAT1360

SPAT

Extensive global examination

1.8

6.3

465

R35

ICD-10 Finland

Polyuria

2.0

6.3

351

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

6.3

130

815

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

6.3

230

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

3.2

6.3

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

11.0

6.3

SPAT1251

SPAT

Organisation of medication

2.3

6.3

211

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

6.3

114

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.5

6.3

149

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

6.3

409

3207

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.9

6.3

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

2.7

6.3

120

M47.8

ICD-10 Finland

Other spondylosis

+∞

6.3

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

6.3

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

+∞

6.3

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

6.3

71700, ,

ICD-8 Finland

+∞

6.3

M23.8

ICD-10 Finland

Other internal derangements of knee

2.0

6.3

325

D07AB08

ATC

desonide; topical

1.5

6.2

187

1278

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.2

6.2

218

K59.0

ICD-10 Finland

Constipation

2.0

6.2

353

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.2

258

1878

NA6CG, ,

SPAT

26.7

6.2

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.2

6.2

256

KH1AD

NOMESCO Finland

CT of urinary organs

2.3

6.2

187

L04AD01

ATC

ciclosporin; systemic

2.7

6.2

115

N07CA01

ATC

betahistine; oral

1.8

6.2

440

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

6.2

168

1125

Z30.2

ICD-10 Finland

Sterilization

1.5

6.2

191

1315

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.8

6.2

104

J01CA08

ATC

pivmecillinam; oral

1.3

6.1

766

6541

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

6.1

620

5159

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

6.1

500

4045

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.4

6.1

I20.09

ICD-10 Finland

Unstable angina

2.4

6.1

169

TAC99

NOMESCO Finland

Other blockade for chronic pain

7.7

6.1

RK210, ,

NOMESCO Finland

7.7

6.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.1

514

4176

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.5

6.1

151

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

6.1

307

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.9

6.1

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

6.1

508

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

6.1

134

855

SBB10

NOMESCO Finland

Dental impressions

1.6

6.1

126

792

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

6.1

509

4134

L29

ICPC

Musculoskeletal sympt/complt other

1.7

6.0

115

707

SPAT1098

SPAT

Exercise ECG

3.1

6.0

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.6

6.0

134

N05CD07

ATC

temazepam; oral

1.7

6.0

103

615

K04.09

ICD-10 Finland

Pulpit UNS

1.8

6.0

547

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

2.3

6.0

183

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.5

6.0

S43.7

ICD-10 Finland

Sprain and strain of other and unspecified parts of shoulder girdle

3.5

6.0

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

6.0

408

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019198) Lymphocytes [#/volume] in Blood

1726

8176

6.70

313.23

9.7

5.7

2.10

1.95

e9/l

2.68

1653

7348

(3008898) HLA-B27 [Presence]

656

613

14.98

307.65

1.1

—

(3006315) Basophils [#/volume] in Blood

1716

7847

6.95

307.65

9.6

5.8

0.04

e9/l

4.00

1629

6876

(40760892) CBC W Ordered Manual Differential panel - Blood

1686

7354

7.05

307.65

9.6

6.1

—

(3001604) Monocytes [#/volume] in Blood

1716

7845

6.95

307.65

9.6

5.7

0.55

0.54

e9/l

0.68

1629

6875

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

518

511

13.05

307.65

1.6

0.05

0.20

iu/ml

0.75

103

(3013115) Eosinophils [#/volume] in Blood

1739

8133

7.03

307.65

9.8

6.1

0.18

e9/l

0.37

1660

7253

(3013650) Neutrophils [#/volume] in Blood by Automated count

1784

9049

6.79

287.82

11.8

9.0

3.75

3.94

e9/l

4.52

1702

7950

(3013707) Erythrocyte sedimentation rate by Westergren method

1963

11381

9.59

256.32

8.3

3.3

9.96

9.65

mm/h

0.59

1903

10596

(3006504) Eosinophils/100 leukocytes in Blood

1533

7448

4.71

243.88

9.8

5.8

2.70

2.78

0.79

1492

7019

(3019069) Monocytes/100 leukocytes in Blood

1539

7503

4.73

243.56

10.1

6.0

8.35

8.21

1.25

1498

7087

(3037522) Nuclear Ab [Titer] in Serum

751

2170

4.79

243.08

1.4

1.3

384.10

579.38

titre

2.68

156

419

(3022096) Basophils/100 leukocytes in Blood

1497

7177

4.60

241.76

9.9

5.9

0.73

0.67

4.01

1455

6738

(3018010) Neutrophils/100 leukocytes in Blood

1549

7739

4.61

233.00

9.5

5.6

54.74

56.45

9.03

1507

7337

(3002030) Lymphocytes/100 leukocytes in Blood

1552

7868

4.52

226.03

9.9

5.7

31.33

29.40

12.76

1511

7460

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1883

11287

6.49

213.73

10.1

6.6

71.16

74.49

u/l

2.64

1838

10657

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

117

22.86

159.27

1.6

2.6

8.90

10.65

mg/l

1.39

(3037467) Urinalysis macro (dipstick) panel - Urine

1737

10871

4.15

157.57

6.2

3.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1350

7722

3.02

131.11

4.8

2.9

0.00

estimate

0.80

301

1563

(3009261) Glucose [Presence] in Urine by Test strip

1356

7803

3.01

129.71

4.8

3.0

0.00

0.01

estimate

1.32

292

1476

(3021601) Nitrite [Presence] in Urine by Test strip

1349

7749

3.00

129.31

6.1

4.1

0.00

estimate

0.50

300

1529

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

639

2438

3.31

127.89

1.3

1.2

11.76

11.29

u/ml

0.06

265

1031

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

20.87

123.51

1.4

1.8

209.10

67.63

au/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

756

3274

3.02

120.54

4.8

2.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

664

2752

3.05

113.51

1.4

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

640

2642

3.03

109.67

1.3

1.2

32.60

24.45

iu/ml

0.37

193

833

(3015736) pH of Urine

1128

6308

2.66

106.64

4.4

2.8

5.92

5.95

0.09

679

(3021879) Hepatitis B virus core Ab [Presence] in Serum

491

1828

3.19

99.72

1.3

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

548

2212

2.98

96.26

3.4

2.5

178.13

111.17

ug/g

2.46

466

1782

(40761535) Cells panel - Urine sediment

304

853

3.99

95.34

4.4

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1098

6344

2.50

92.82

2.7

2.1

74.37

73.89

nmol/l

0.25

1050

5914

(3002179) Metamyelocytes/100 leukocytes in Blood

337

1075

3.53

87.14

4.6

4.1

0.49

0.60

0.28

303

(3017181) Myelocytes/100 leukocytes in Blood

351

1164

3.41

85.30

5.0

4.3

0.50

0.94

2.75

102

349

(3025159) Blasts/100 leukocytes in Blood

330

1068

3.47

83.24

5.1

4.5

0.04

0.79

0.96

251

(3021440) Promyelocytes/100 leukocytes in Blood

338

1118

3.40

82.32

5.1

4.4

0.05

0.10

0.94

304

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2079

17223

7.83

79.97

18.2

9.5

13.91

21.22

mg/l

36.00

1817

12919

(3029937) Albumin [Presence] in Urine by Test strip

764

3966

2.44

78.66

5.7

3.1

0.00

estimate

1.08

295

1492

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

202

481

4.53

78.37

1.5

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

12.42

78.28

2.6

2.5

29.14

53.38

au/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

11.50

76.43

2.7

3.1

7.23

9.02

mg/l

1.12

(3019150) Specific gravity of Urine by Refractometry

644

3170

2.47

73.74

5.5

3.2

1.02

kg/l

1.12

481

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1006

6086

2.23

70.31

5.1

2.9

—

(3021589) Normoblasts [#/volume] in Blood

1138

7269

2.21

69.00

11.8

8.0

0.00

e9/l

0.20

1019

5944

(3015171) Extractable nuclear Ab [Units/volume] in Serum

215

591

3.93

68.67

1.3

1.2

1.66

0.86

u/ml

0.25

(40758558) Short blood count panel - Blood

702

3792

2.27

63.32

8.0

6.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

792

4520

2.19

62.12

1.6

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

905

5476

2.13

60.73

4.8

4.5

37.09

36.68

g/l

1.38

841

5138

(3018095) Leukocytes [#/volume] in Urine

819

4903

2.08

55.25

3.6

3.1

34.67

93.24

e6/l

3.66

537

3188

(3000475) Leukocytes [#/volume] in Synovial fluid

116

238

5.10

53.60

1.9

1.7

7053.75

13808.95

e6/l

1.33

174

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2081

18215

5.85

52.75

17.4

10.5

70.32

71.29

umol/l

1.02

2081

18209

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

120

264

4.76

51.05

1.6

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

949

6161

1.97

49.57

5.4

5.9

1.22

1.21

mmol/l

1.03

815

5228

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2084

18475

5.57

47.11

17.2

8.0

26.70

26.44

u/l

0.22

2059

17896

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

606

3405

2.09

47.05

2.1

2.0

129.22

247.58

u/l

2.69

580

3216

(3022145) Colonoscopy Study observation

341

1534

2.45

45.27

1.4

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

852

5477

1.92

44.52

4.8

5.2

1.22

1.21

mmol/l

1.06

790

5032

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

408

2009

2.27

43.95

2.3

0.94

1.30

e6/l

0.73

279

1077

(3031040) Bacteria [#/volume] in Urine by Automated count

1353

10187

1.89

42.28

4.6

3.5

91.50

1430.81

e6/l

—

118

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

113

6.37

41.67

1.5

1.7

51.38

55.18

0.27

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

593

3449

1.99

40.96

2.5

2.0

2.73

2.80

mg/l

0.41

541

2959

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1018

7098

1.83

39.84

5.0

5.7

9.40

10.87

umol/l

7.41

953

6718

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

682

4195

1.92

39.74

2.9

2.3

54.16

58.61

u/l

1.92

641

3908

(3021788) Differential panel - Synovial fluid

195

4.77

38.96

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

263

1129

2.52

38.29

2.3

2.7

10.63

10.59

g/l

0.05

250

1040

(3017732) Neutrophils [#/volume] in Blood

255

1086

2.53

37.74

2.3

2.5

4.06

4.56

e9/l

0.89

211

950

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1867

15959

2.31

37.73

12.5

8.6

94.44

91.58

ml/min/173m2

7.92

1626

12872

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

247

1041

2.55

37.35

2.5

2.3

19.57

24.22

au/ml

0.41

120

(3030467) Casts [#/volume] in Urine by Automated count

587

3523

1.92

36.29

2.9

2.6

0.24

0.38

e6/l

1.32

469

2592

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

231

961

2.57

35.83

1.3

55.00

51.05

au/ml

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

109

297

3.81

34.95

4.5

3.5

56.62

55.95

0.25

109

297

(3044941) Cell count panel - Synovial fluid

167

4.81

34.25

1.5

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

682

4376

1.82

33.69

3.3

2.6

153.84

43.22

ng/l

0.37

342

2196

(36304419) Bacteria [Presence] in Urine

574

3532

1.85

32.24

2.7

2.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

6.55

32.03

1.5

40.51

33.35

0.50

(3000850) Epithelial cells [#/volume] in Urine

458

2634

1.94

31.61

2.3

5.30

8.23

e6/l

4.62

424

2350

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

196

806

2.58

31.02

2.2

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

1800

15486

2.01

30.77

18.6

12.0

14.56

14.22

1.88

1792

15183

(3018418) pH of Serum or Plasma

570

3580

1.81

29.55

3.2

3.7

7.40

0.20

106

729

(3028026) IgM [Mass/volume] in Serum or Plasma

204

884

2.45

28.85

1.6

1.9

1.28

1.44

g/l

1.12

198

826

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

185

766

2.55

28.83

1.2

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

547

3422

1.80

28.59

2.1

2.3

797.96

3407.10

umol/l

3.24

474

3138

(3036071) Salmonella sp Ab [Titer] in Serum

6.54

27.76

1.1

1.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

128

451

2.95

27.21

1.6

1.9

0.24

0.23

g/l

0.37

119

422

(3019550) Sodium [Moles/volume] in Serum or Plasma

1877

16578

2.06

27.01

12.9

9.9

139.54

139.61

mmol/l

0.79

1829

16049

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1083

8244

1.63

26.78

3.1

2.7

104.17

86.54

ug/l

0.57

1033

7793

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

129

466

2.88

26.22

1.6

1.9

1.24

1.17

g/l

1.69

120

436

(3023103) Potassium [Moles/volume] in Serum or Plasma

1880

16655

2.05

26.18

13.0

10.0

3.92

mmol/l

0.38

1833

16070

(3022217) INR in Platelet poor plasma by Coagulation assay

746

5193

1.67

26.13

8.4

9.3

1.13

1.15

inr

0.22

229

1722

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

133

493

2.81

25.77

1.1

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

595

3911

1.72

25.76

3.0

2.7

22.25

115.91

e6/l

1.88

473

2921

(3041096) Erythrocytes [Presence] in Urine by Automated

681

4643

1.68

25.74

3.8

2.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

5.62

25.42

1.5

6625.53

57106.60

e6/l

0.75

(46235355) HIV 1 and 2 tests - Meaningful Use set

784

5577

1.64

24.94

1.8

2.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1061

8135

1.60

24.72

4.2

4.0

6.19

6.45

mmol/l

4.71

966

7396

(3022948) Iron [Moles/volume] in Serum or Plasma

351

1995

1.91

24.54

2.2

2.3

13.09

14.42

umol/l

2.66

337

1870

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

120

439

2.84

23.82

1.3

1.2

29.89

43.57

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

547

3600

1.70

23.19

1.5

1.4

2.30

2.22

g/l

0.55

380

2348

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

319

1788

1.92

23.18

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

709

4990

1.63

23.15

1.9

1.7

97.64

98.27

pmol/l

0.13

418

2719

(40761511) CBC panel - Blood by Automated count

2018

18557

2.49

22.74

15.0

9.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

321

1825

1.89

22.28

2.1

2.3

2.46

2.43

g/l

0.56

301

1697

(3045414) Leukocytes [Presence] in Urine

144

598

2.51

22.24

1.9

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

394

2412

1.78

21.45

2.5

2.9

537.42

966.65

ng/l

2.32

314

1962

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

295

1668

1.89

20.74

2.2

2.4

22.42

24.17

1.20

255

1453

(3019309) Folate [Moles/volume] in Red Blood Cells

327

1916

1.83

20.53

1.8

1.6

1189.54

1163.64

nmol/l

0.21

269

1475

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

508

3377

1.66

20.36

1.8

1.7

1.00

0.95

mg/l

0.15

370

2451

(3023368) Bacteria identified in Blood by Culture

458

2963

1.69

20.36

4.2

3.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

253

1370

1.96

20.23

5.5

4.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

255

1385

1.95

20.21

2.4

1.9

355.07

381.42

nmol/l

1.56

231

1284

(3015377) Calcium [Moles/volume] in Serum or Plasma

628

4423

1.59

19.83

2.3

3.2

2.34

2.35

mmol/l

1.25

560

4038

(3009542) Hematocrit [Volume Fraction] of Blood

2115

20092

4.89

19.62

26.0

14.4

40.64

40.79

0.26

2023

19120

(3007461) Platelets [#/volume] in Blood

2116

20110

5.00

19.58

26.3

14.3

272.86

259.47

e9/l

18.62

2098

19627

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

404

2.71

19.48

1.3

1.2

2.78

7.39

u/ml

0.85

(3025941) Bacteria identified in Stool by Culture

195

975

2.10

19.42

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

105

402

2.69

19.13

1.3

1.2

1.13

3.89

u/ml

—

(3024731) MCV [Entitic volume]

2116

20131

4.91

19.10

26.0

14.3

90.64

89.94

11.67

2109

19881

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

280

3.04

19.08

1.7

1.4

—

(3035941) MCH [Entitic mass]

2116

20133

4.91

19.05

26.0

14.3

30.15

30.06

1.67

2109

19881

(3026361) Erythrocytes [#/volume] in Blood

2116

20136

4.89

18.98

26.2

14.3

4.52

4.57

e12/l

6.18

2097

19624

(3010813) Leukocytes [#/volume] in Blood

2116

20138

4.89

18.94

26.2

14.4

6.84

6.64

e9/l

2.94

2097

19611

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

595

4181

1.59

18.79

1.3

0.81

1.44

u/ml

1.71

165

1161

(3000963) Hemoglobin [Mass/volume] in Blood

2116

20147

4.85

18.73

26.3

14.4

135.52

136.65

g/l

3.99

2109

19889

(3020630) Protein [Mass/volume] in Serum or Plasma

157

734

2.23

18.53

1.7

2.4

68.36

67.28

g/l

0.98

140

685

(3004616) Nuclear Ab [Presence] in Serum

178

3.56

18.47

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

143

644

2.31

18.44

1.9

2.2

37.27

38.16

u/l

0.23

133

597

(3004588) Protein electrophoresis panel - Serum or Plasma

132

582

2.35

17.88

1.8

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

108

445

2.50

16.97

1.2

1.4

94.00

86.15

titre

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1769

15881

1.65

16.94

5.0

4.4

1.70

2.18

mu/l

1.86

1676

14908

(3021960) Folate [Moles/volume] in Serum or Plasma

404

2654

1.64

16.58

1.6

1.4

18.87

20.73

nmol/l

2.37

360

2330

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

273

2.89

16.24

1.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

165

3.46

16.07

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

161

3.48

15.94

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

161

3.48

15.94

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

166

3.44

15.93

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

166

3.44

15.93

1.6

1.5

—

(40768797) Stomach Pathology biopsy report

294

1793

1.74

15.90

1.1

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

212

1171

1.90

15.87

1.6

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

162

3.46

15.80

1.6

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

209

1154

1.90

15.66

1.6

—

(3019225) pH of Specimen

214

1193

1.88

15.57

2.9

3.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

344

2.62

15.43

1.3

1.2

24.30

36.74

u/ml

0.42

(3013512) EKG study

490

3423

1.56

15.42

2.8

2.9

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

6.11

15.13

1.3

1.20

1.15

—

(3042936) Bacteria identified in Isolate by Culture

296

1833

1.71

15.11

2.1

1.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

326

2089

1.66

14.61

2.2

2.7

2.42

2.43

mmol/l

0.42

271

1838

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1530

13486

1.47

14.01

4.4

3.9

14.56

14.44

pmol/l

1.32

1439

12516

(3007853) Bacteria identified in Skin by Aerobe culture

264

1618

1.72

13.95

1.9

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

300

2.63

13.62

1.3

1.2

1.28

1.40

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

505

3653

1.50

13.26

2.0

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

243

2.77

13.04

1.4

1.9

0.53

0.75

g/l

0.99

187

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

425

2.32

12.93

2.0

2.3

10.10

10.61

mg/l

0.27

404

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

100

453

2.27

12.76

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

540

3987

1.47

12.73

2.9

2.3

—

(40768443) Skin Pathology biopsy report

115

553

2.14

12.68

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

100

461

2.23

12.25

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

138

3.31

12.20

1.4

1.5

6.63

6.57

g/l

0.03

(3024139) IgG subclass 3 [Mass/volume] in Serum

138

3.31

12.20

1.4

1.5

0.41

0.38

g/l

0.23

(3014765) Yersinia sp identified in Stool by Organism specific culture

457

2.22

12.09

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

139

3.29

12.06

1.4

1.5

3.04

2.82

g/l

0.30

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

694

5418

1.42

11.99

3.5

3.0

32.95

30.30

u/l

0.74

663

5158

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

382

2.33

11.96

1.3

1.4

18.31

22.62

u/l

0.71

324

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

198

2.88

11.94

1.2

1.4

—

(4062490) Immunoglobulin typing, IgG

137

3.26

11.65

1.4

1.5

—

(4034850) Laboratory test

438

2.22

11.65

10.2

6.3

—

(3014051) Protein [Presence] in Urine by Test strip

319

2.43

11.55

2.9

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

541

4073

1.44

11.32

2.1

2.2

—

(3020891) Body temperature

362

2.32

11.15

4.1

4.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

383

2707

1.51

11.04

1.7

1.6

49003271.79

33390615.71

pmol/l

0.17

351

2345

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

102

3.57

11.03

1.5

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

102

3.57

11.03

1.5

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

143

782

1.89

11.03

3.3

4.1

69.19

80.21

ng/l

0.70

128

702

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

137

740

1.91

10.97

2.4

2.0

4.26

7.81

ug/l

2.13

120

653

(3005322) IgE [Units/volume] in Serum or Plasma

191

1145

1.73

10.88

1.3

210.91

212.60

u/ml

0.01

185

1064

(3019060) Gas panel - Arterial blood

114

585

2.00

10.60

5.2

5.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

432

2.16

10.41

1.6

1.7

162.50

207.14

titre

—

(3022621) pH of Urine by Test strip

158

913

1.79

10.22

3.2

2.4

—

(3045424) Erythrocytes [Presence] in Urine

241

2.53

10.05

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1714

15758

1.44

10.01

3.7

3.4

5.64

5.69

mmol/l

1.16

1602

14646

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

604

4722

1.39

9.99

1.8

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

281

1925

1.53

9.30

2.7

2.5

2.96

3.56

e6/l

0.36

156

989

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

467

2.04

9.21

2.3

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

169

1026

1.70

9.20

2.2

2.1

77.04

74.70

ml/min/173m2

0.27

369

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

884

7405

1.33

9.15

2.6

2.4

—

(3037756) Immunofixation for Serum or Plasma

170

2.74

9.11

1.3

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

121

3.09

9.10

2.1

3.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

323

2.24

9.05

2.0

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

4.10

8.98

1.5

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.22

8.92

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

102

3.27

8.90

1.2

1.1

—

2.00

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

319

2.23

8.90

1.2

1.3

3.63

3.66

mmol/l

0.09

301

(3052851) Hemolysis interference index of Serum or Plasma

372

2.14

8.86

2.2

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

305

2155

1.48

8.68

3.4

2.9

306.09

511.42

ng/l

0.39

164

1311

(3016650) Hepatitis A virus Ab [Presence] in Serum

304

2.24

8.61

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

235

2.42

8.60

1.1

1.2

—

106.67

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

100

529

1.93

8.57

2.4

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.07

8.52

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

459

3510

1.39

8.48

2.1

2.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

223

1482

1.56

8.45

4.4

6.2

1.05

1.04

mmol/l

0.16

202

1402

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

116

649

1.83

8.38

2.7

3.0

5.05

5.17

kpa

1.00

109

629

(40768804) Tissue Pathology biopsy report

784

6518

1.32

8.34

2.0

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

110

607

1.86

8.30

1.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

214

1416

1.57

8.26

2.3

3358.02

6088.90

u/l

1.08

591

(3018405) Lactate [Moles/volume] in Arterial blood

330

2.16

8.21

3.6

4.3

1.32

1.41

mmol/l

0.30

325

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

151

2.75

8.20

1.2

1.5

—

(36660697) Celiac disease serology panel - Serum

221

1478

1.55

8.14

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

366

2.09

8.06

2.1

2.2

0.93

2.37

ug/l

0.99

333

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1593

14632

1.35

8.03

3.9

3.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

180

1151

1.62

8.03

2.1

3.0

1.70

1.74

0.23

156

1036

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

137

2.81

7.92

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

143

2.76

7.88

1.2

1.3

—

(3009343) pH of Capillary blood

113

643

1.80

7.74

2.7

3.0

7.41

0.06

(3028433) Virus identified in Specimen by Culture

4.35

7.68

1.5

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

316

2.12

7.47

1.5

1.3

288.11

303.94

ug/g

0.21

166

(3004716) Salmonella sp identified in Stool by Organism specific culture

175

1133

1.59

7.42

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

324

2.10

7.40

1.3

1.5

351.47

858.05

e6/l

0.40

257

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

325

2.10

7.34

1.2

1.5

57.77

18.87

e6/l

0.55

245

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

115

2.90

7.33

1.8

30.73

26.31

mg/l

0.15

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

281

2.17

7.20

2.0

1.8

0.23

0.76

g/l

1.44

254

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

134

818

1.68

7.19

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1562

14388

1.32

7.17

4.5

4.3

37.01

38.06

mmol/mol

5.46

1472

13577

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

231

2.28

7.08

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

463

1.89

7.05

2.6

2.4

1.25

1.27

0.07

457

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

449

1.91

7.03

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

3.27

6.83

1.1

1.2

—

(3024263) Appearance of Synovial fluid

3.80

6.81

1.8

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

126

2.73

6.77

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.90

6.71

1.1

1.3

81.93

96.41

nmol/24h

0.53

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

344

2.01

6.69

1.9

2.3

546.82

298.96

ug/l

0.29

319

(3012095) Magnesium [Moles/volume] in Serum or Plasma

268

1946

1.43

6.57

3.0

3.5

0.82

0.83

mmol/l

1.02

249

1851

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

461

1.86

6.51

1.7

2.1

1.65

1.39

g/l

1.26

403

(3048929) Epstein Barr virus Ab [Presence] in Serum

128

793

1.65

6.51

1.3

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

454

1.86

6.50

2.5

2.3

0.71

0.67

0.44

449

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

105

617

1.74

6.49

2.7

3.0

1.24

1.71

mmol/l

0.72

450

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.94

6.44

1.1

1.2

—

(3044889) 12 lead EKG panel

1143

10194

1.26

6.40

3.1

2.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

223

2.23

6.34

2.2

2.9

27.79

43.67

mg/l

0.59

178

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

340

1.97

6.19

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

225

1603

1.45

6.11

2.7

2.5

4.95

7.32

umol/l

4.03

197

1379

(3028679) Herpes simplex virus Ab [Presence] in Serum

116

2.70

6.09

1.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

287

2.05

6.09

2.8

2.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

227

1622

1.45

6.07

3.5

30.96

31.87

0.69

180

1193

(1761868) Lipid panel - Serum or Plasma

623

7364

0.78

6.04

2.2

2.3

—

(3023520) Reticulocytes [#/volume] in Blood

125

786

1.63

6.02

1.9

2.9

73.37

72.82

e9/l

0.06

578

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

171

2.36

5.99

1.1

—

(21494755) Public health laboratory ask at order entry panel

212

2932

0.69

5.99

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

440

3510

1.32

5.97

3.4

3.5

94.46

95.22

0.30

427

3416

(3000494) Fungus identified in Specimen by Culture

237

1713

1.43

5.96

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

223

2.18

5.93

2.2

3.0

38.26

75.70

mg/l

0.69

176

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

339

1.95

5.90

1.3

1.4

—

5.00

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

333

1.95

5.86

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

463

1.80

5.84

2.5

3.2

0.29

0.28

g/l

0.02

216

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

428

1.83

5.77

1.4

1.2

306.64

260.21

u/ml

0.57

265

(3039162) Centromere protein B Ab [Units/volume] in Serum

187

2.27

5.75

1.4

1.3

2.48

48.53

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

121

2.58

5.63

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

121

2.58

5.63

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

121

2.58

5.63

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

121

2.58

5.63

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

121

2.58

5.63

1.3

1.1

—

(3047181) Lactate [Moles/volume] in Blood

338

1.92

5.62

6.0

6.6

1.43

1.21

mmol/l

0.89

297

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

574

1.70

5.62

2.4

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

171

1174

1.50

5.61

2.1

2.2

0.23

0.22

g/l

0.24

160

1116

(3018677) aPTT in Platelet poor plasma by Coagulation assay

251

1853

1.40

5.60

2.0

2.1

29.93

29.48

0.54

238

1792

(3022313) Gas panel - Capillary blood

477

1.77

5.58

2.9

3.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

122

2.56

5.54

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

141

2.43

5.46

1.7

1.6

—

(3015183) Erythrocyte sedimentation rate

129

2.50

5.46

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

211

1518

1.43

5.44

1.2

79.44

158.91

iu/ml

3.06

581

(3044640) Blood type and Crossmatch panel - Blood

567

4732

1.27

5.38

2.2

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.56

5.32

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.56

5.32

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

146

982

1.52

5.29

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

412

1.80

5.24

3.1

3.2

24.56

24.77

mmol/l

0.31

382

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

319

1.91

5.19

1.5

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.35

5.16

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

265

1.99

5.09

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

322

1.89

5.06

1.2

1.6

—

(3002032) Base excess in Venous blood by calculation

141

953

1.51

5.01

3.8

3.6

1.64

1.69

mmol/l

0.07

123

787

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.71

4.99

1.5

1.2

90.87

90.56

0.01

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

149

2.30

4.87

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.50

4.77

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

132

2.37

4.74

1.3

1.9

—

(40761536) Microorganisms panel - Urine sediment

198

1450

1.40

4.64

4.1

3.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

2.50

4.63

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

2.50

4.63

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

2.50

4.63

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.92

4.60

1.4

1.1

—

(3026782) Osmolality of Urine

324

2570

1.31

4.52

2.9

2.5

544.34

546.15

mosm/kgh2o

0.05

286

2198

(3049717) Cytology report of Urine Cyto stain

270

1.91

4.51

2.1

2.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.87

4.49

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1782

17009

1.28

4.43

3.9

3.7

2.86

2.89

mmol/l

1.09

1680

16083

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

125

2.34

4.34

1.9

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

184

2.08

4.31

1.3

1.5

—

(3000330) Specific gravity of Urine by Test strip

593

1.59

4.31

3.2

2.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

175

1274

1.41

4.26

2.6

4.4

217.33

240.16

u/l

1.83

160

1220

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

588

1.59

4.23

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

220

1.97

4.22

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

220

1.97

4.22

1.4

1.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

6.95

4.16

1.8

2.2

4.26

3.72

mg/l

—

(3012516) Albumin [Mass/volume] in Urine

396

3256

1.27

4.15

2.9

3.5

1243.45

347.03

mg/l

1.16

229

2140

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

300

1.82

4.15

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.90

4.13

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.35

4.12

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.81

4.12

1.7

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.81

4.12

1.7

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.09

4.08

1.4

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

142

1004

1.44

4.07

2.7

3.2

1.23

mmol/l

0.18

128

863

(40760888) Immunoglobulin light chains.free panel - Serum

175

2.08

4.06

1.5

3.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.21

4.05

1.1

—

(3016502) Oxygen saturation in Arterial blood

138

972

1.45

4.04

7.0

8.8

96.64

96.32

0.44

133

945

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

189

2.03

4.04

1.4

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

245

1.90

4.03

1.7

3.0

—

2527.40

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

416

1.68

4.01

1.3

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.21

4.01

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.21

4.01

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.91

3.99

1.1

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1696

16152

1.24

3.93

3.3

3.2

1.24

1.25

mmol/l

0.13

1603

15252

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.08

3.90

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

138

2.19

3.90

1.4

1.2

1.09

1.05

ratio

0.56

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.30

3.86

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.78

3.85

1.2

1.5

148.73

125.58

nmol/l

1.13

(3009508) Creatinine [Moles/volume] in Urine

473

4000

1.23

3.85

3.1

3.4

8.15

8.05

mmol/l

0.14

403

3518

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.44

3.80

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

535

1.57

3.72

1.1

2.24

5.00

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

150

1091

1.40

3.70

1.1

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.61

3.70

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

109

2.31

3.69

1.0

1.1

1249.32

1418.74

miu/ml

0.41

109

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.69

3.67

1.0

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1758

16841

1.24

3.67

3.7

3.5

4.72

4.79

mmol/l

2.56

1671

16034

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

142

2.13

3.65

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

306

1.75

3.62

1.3

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

539

1.56

3.61

1.4

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

130

2.17

3.58

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

249

1.82

3.54

2.2

1.9

5.32

5.25

mmol/24h

0.05

222

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.89

3.49

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

333

1.70

3.47

1.6

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

151

1113

1.38

3.46

6.7

8.1

5.03

5.04

kpa

0.08

145

1074

(3027801) Oxygen [Partial pressure] in Arterial blood

151

1113

1.38

3.46

6.6

8.1

12.89

13.57

kpa

0.80

146

1074

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1749

16771

1.23

3.46

3.6

3.4

1.47

1.48

mmol/l

0.46

1658

15896

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.02

3.37

2.1

2.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

262

1.77

3.32

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

470

4030

1.21

3.30

1.6

1.5

—

(4200892) Spirometry reversibility

123

883

1.42

3.30

1.4

—

(3000492) Spirometry study

223

1757

1.30

3.29

1.5

1.4

—

(3006462) Nitrate [Presence] in Urine

2.79

3.25

4.1

2.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.35

3.19

1.1

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.38

3.18

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.38

3.18

1.1

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.81

3.18

1.4

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

397

1.60

3.15

1.3

1.4

89.40

101.63

u/ml

0.47

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

124

2.11

3.14

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.68

3.08

1.2

—

(3003396) Base excess in Arterial blood by calculation

149

1119

1.36

3.07

6.8

8.1

1.07

0.94

mmol/l

0.14

117

893

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

488

1.53

3.06

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

126

2.08

3.02

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.30

2.99

1.0

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.64

2.96

1.7

1.2

0.29

0.28

g/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.72

2.92

1.1

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

304

1.66

2.90

1.2

1.3

5.37

3.56

u/ml

0.28

108

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.72

2.88

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.72

2.88

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.72

2.88

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.72

2.88

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.51

2.87

1.2

1.3

140.25

172.63

mmol/24h

0.73

(3043238) Trisomy 21 risk [Likelihood] in Fetus

971

0.66

2.82

1.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

706

1.42

2.80

3.0

2.7

166.09

153.26

ng/l

0.12

612

(3032057) Clostridioides difficile [Presence] in Stool

3.92

2.77

2.8

2.0

—

(40768441) Liver Pathology biopsy report

117

2.06

2.77

1.3

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

159

1.90

2.76

1.1

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

210

1.78

2.75

1.4

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

945

0.67

2.64

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

106

2.09

2.63

1.2

1.1

1.28

1.05

u/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

142

1087

1.33

2.62

2.3

2.1

12.05

12.57

nmol/l

0.32

135

1003

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.47

2.62

1.3

2.2

307.78

143.09

umol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.68

2.59

1.1

1.3

—

(3005033) Fetal Nuchal fold Thickness US

941

0.67

2.59

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

307

1.61

2.57

1.3

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.36

2.55

3.4

2.9

23.27

23.09

ug/l

0.01

(3020682) Albumin/Creatinine [Ratio] in Urine

396

3423

1.19

2.53

3.4

4.1

9.80

10.37

mg/mmol

0.10

227

2264

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

157

1.86

2.52

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

122

1.98

2.50

1.5

1.7

—

(3000991) Gas panel - Venous blood

120

903

1.35

2.49

6.2

8.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

691

1.39

2.44

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

168

1332

1.28

2.41

2.5

2.2

39.74

75.51

u/l

0.50

140

1164

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.01

2.40

1.0

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

729

1.38

2.37

1.5

1.4

9.17

8.77

u/l

0.11

600

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.22

2.30

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

278

2347

1.21

2.29

3.0

3.4

1.33

1.92

ug/l

2.51

254

2141

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

232

1923

1.23

2.29

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.13

2.28

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

414

1.49

2.28

2.0

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.56

2.27

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

448

1.46

2.26

2.2

2.3

4.52

5.82

umol/l

0.87

337

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

120

1.93

2.25

1.4

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1318

12513

1.14

2.25

3.2

2.7

44.20

38.45

u/l

1.53

1247

11960

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.16

2.24

1.9

1.8

1.40

5.65

u/field

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

180

1.73

2.19

3.9

5.0

31.85

51.23

u/ml

0.47

(21494890) Protein electrophoresis panel - 24 hour Urine

2.13

2.18

1.8

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

226

1.65

2.18

1.4

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.25

2.17

1.1

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

338

2932

1.18

2.08

1.5

1.4

—

(3001729) Color of Synovial fluid

5.01

2.07

2.6

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

191

1.69

2.07

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

123

960

1.30

2.03

1.4

1.3

260.31

235.27

miu/ml

0.33

478

(3014007) Fractional oxyhemoglobin in Arterial blood

612

1.37

2.01

7.1

10.1

94.74

94.42

0.37

607

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.08

2.01

2.6

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

716

1.34

2.01

1.5

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

1.93

2.00

1.4

2.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.97

2.00

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

1.62

2.00

1.1

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.29

1.97

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

146

1170

1.27

1.97

2.8

3.5

4.63

4.59

pmol/l

0.10

133

1054

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

127

1.82

1.94

2.5

2.7

36593.90

41045.76

ug/l

0.71

127

(3011985) Renin [Units/volume] in Plasma

173

1.69

1.90

2.0

1.6

73.26

44.38

mu/l

0.41

155

(3023323) Follitropin [Units/volume] in Serum or Plasma

161

1314

1.24

1.87

1.4

1.3

18.54

24.16

iu/l

1.93

147

1119

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

622

1.35

1.84

6.8

9.9

1.43

1.31

0.53

617

(44813793) Dust mix specific IgE antibody measurement

122

1.81

1.84

1.3

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

115

1.83

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

168

1.68

1.80

1.1

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

256

1.53

1.76

1.5

2.1

134.86

132.20

g/l

0.27

193

(3021901) Oxygen saturation in Capillary blood

162

1.68

1.75

1.5

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.94

1.75

1.2

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

123

983

1.27

1.73

6.3

8.0

8.35

7.82

mmol/l

0.37

114

949

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

194

1.61

1.72

1.1

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

103

1.85

1.71

5.9

7.6

—

(3012501) Base excess in Blood by calculation

266

1.51

1.71

3.0

2.9

2.66

2.33

mmol/l

0.25

166

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.19

1.67

2.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.19

1.67

2.1

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.19

1.67

2.1

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.10

1.65

2.1

2.2

—

23.77

—

(3023419) Bacteria identified in Sputum by Culture

127

1.74

1.64

2.6

3.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

292

2555

1.17

1.64

1.7

1.41

1.37

0.29

259

2340

(1616796) Gas panel - Central venous blood

238

1.52

1.60

2.5

2.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

1.59

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

281

2457

1.17

1.59

1.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1246

0.78

1.58

1.5

—

(3011648) Oxygen content in Venous blood

1.85

1.56

2.4

2.3

10.64

11.45

0.27

(40768795) Lymph node Pathology biopsy report

159

0.44

1.54

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

115

1.75

1.52

3.3

3.2

—

(3051593) INR in Capillary blood by Coagulation assay

2.60

1.51

4.4

4.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

137

1653

0.82

1.51

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

522

1.33

1.49

4.4

3.8

24.05

23.88

mmol/l

0.24

509

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.91

1.49

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.44

1.48

1.0

2.1

—

(3052592) Norovirus Ag [Presence] in Stool

3.13

1.44

2.8

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

149

1.62

1.41

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

204

2355

0.85

1.39

1.5

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

679

1.28

1.38

1.6

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.08

1.38

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

142

1.63

1.38

1.1

1.4

190.61

168.69

pmol/l

0.34

142

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

128

1061

1.22

1.35

2.8

4.4

4.34

26.47

ug/l

1.57

797

(3045683) HLA typing for celiac disease panel - Blood or Tissue

143

1.61

1.35

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

115

943

1.23

1.35

1.4

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.76

1.35

1.9

2.1

2.29

2.35

u/field

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.9

—

2.14

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.15

1.33

3.1

2.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

152

1.59

1.32

1.1

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

1.59

1.32

1.2

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

152

1.59

1.32

1.1

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

117

966

1.22

1.29

2.5

2.9

24.74

40.21

u/ml

1.54

111

939

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

301

1.40

1.29

1.2

1.3

3.00

4.00

u/ml

0.64

132

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.78

1.28

1.0

1.2

1.42

1.82

umol/24h

—

(40767503) Oxygen content in Capillary blood by calculation

210

1.48

1.28

1.6

2.1

17.11

17.21

0.05

100

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.09

1.27

2.4

3.9

—

(3029075) Extractable nuclear Ab panel - Serum

2.05

1.26

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

118

0.42

1.24

1.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

123

1.63

1.24

1.1

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.05

1.22

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.64

1.21

2.8

2.6

0.60

0.95

u/field

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

116

1.64

1.21

1.2

2.3

31.68

32.09

0.15

116

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

213

1.46

1.20

1.4

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

471

1.30

1.19

1.8

2.1

2.73

5.02

iu/l

3.75

187

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.11

1.18

2.1

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.88

1.18

1.0

1.1

106.43

91.53

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1154

0.82

1.17

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.00

1.16

1.2

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.00

1.16

1.2

2.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1153

0.82

1.16

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

209

1837

1.15

2.7

3.0

20.72

21.12

0.12

624

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.06

1.15

1.3

1.4

153.55

112.09

nmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1151

0.82

1.14

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1149

0.82

1.13

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

111

1.63

1.12

2.8

2.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.79

1.11

1.0

12.75

14.52

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.26

1.10

1.3

1.1

—

(3023410) Appearance of Cerebral spinal fluid

160

1.51

1.09

1.1

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

112

1.61

1.09

1.2

1.1

9.87

10.12

iu/ml

—

(3001556) Androgen free Index in Serum or Plasma

2.19

1.08

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

462

1.28

1.06

1.5

0.38

0.42

nmol/l

0.20

382

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.65

1.06

1.9

2.8

46.22

45.11

—

(3051611) Lipemic interference index of Serum or Plasma

121

1.58

1.05

3.1

3.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.96

1.03

1.9

4.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.28

1.03

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

376

1.31

1.03

1.0

1.1

2.02

3.66

u/ml

1.01

183

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

146

1.51

1.03

1.1

—

(3017569) Oxygen content in Arterial blood

1.92

1.02

1.4

3.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

503

1.26

0.99

1.1

0.95

2.63

u/ml

2.02

251

(3050129) First trimester maternal screen panel - Serum or Plasma

164

1435

1.15

0.99

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.84

0.98

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

108

1.58

0.96

1.7

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

132

1522

0.86

0.95

1.8

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.89

0.94

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.89

0.94

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.89

0.94

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.89

0.94

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

101

1.59

0.93

1.4

1.6

—

787478.75

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

1.56

0.93

1.4

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.23

0.93

1.0

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

464

1.26

0.91

1.0

1.1

8.66

6.08

u/ml

0.27

245

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.15

0.91

1.2

2.9

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

202

1.39

0.89

2.2

2.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

128

0.55

0.88

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.79

0.87

3.7

2.8

0.64

1.17

ug/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

111

1.54

0.87

1.5

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

307

1.31

0.87

1.0

0.03

0.38

u/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

343

1.29

0.86

1.0

1.1

1.74

4.36

u/ml

1.52

143

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

264

1.33

0.86

2.0

2.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

112

1.52

0.85

1.4

1.2

72.65

75.87

umol/l

0.46

112

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.74

0.82

1.6

1.5

8.07

7.71

ug/l

—

(3034426) Prothrombin time (PT)

1.70

0.82

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.88

0.81

1.5

2.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

508

1.23

0.81

2.2

2.5

3.80

3.66

g/l

0.29

480

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

103

887

1.17

0.80

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

147

0.61

0.79

1.1

1.3

1.50

1.58

g/l

—

147

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

166

1.39

0.75

1.0

1.5

—

(3008607) Semen analysis panel

2.09

0.74

1.2

—

(3000012) Reticulocyte production index

116

1.47

0.74

1.6

2.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

345

0.75

0.73

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

0.56

0.72

1.0

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.67

0.72

1.2

3.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.75

0.71

3.0

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.75

0.71

3.0

3.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

435

1.22

0.71

1.0

1.1

2.06

1.59

u/ml

0.12

217

(3024928) Oxygen saturation in Venous blood

229

1.31

0.71

3.3

2.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

444

0.78

0.71

1.7

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

143

1.40

0.70

1.1

1.3

—

(1002224) Polysomnography panel

101

881

1.15

0.69

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.64

0.68

1.1

1.2

102.70

116.60

—

(3042517) Benzodiazepines panel - Urine

1.85

0.68

2.0

2.8

—

(3014271) Vancomycin [Susceptibility]

1.85

0.68

2.0

2.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.79

0.66

1.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

294

0.75

0.66

1.6

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.54

0.65

1.1

1.4

—

(3004451) EKG impression Narrative

1.59

0.65

1.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

154

0.65

0.64

1.3

0.75

0.97

g/l

—

154

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

199

2170

0.91

0.63

1.5

—

(3012565) Volume of 24 hour Urine

1.55

0.62

2.1

2.4

2070.00

1862.67

0.23

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.60

0.61

1.5

2.4

12.14

16.78

umol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

165

1.34

0.60

1.1

1.0

—

titre

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

372

1.21

0.59

3.0

4.1

71.49

683.01

u/ml

0.97

324

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.53

0.59

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

309

1.23

0.58

1.1

1.0

0.94

2.87

u/ml

2.14

182

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

106

944

1.13

0.57

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

439

1.19

0.56

1.0

1.1

0.84

1.44

u/ml

0.68

190

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.46

0.56

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.54

0.55

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

385

3649

1.07

0.55

1.6

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

543

1.17

0.54

10.5

10.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

676

1.14

0.52

5.9

6.9

24.68

24.59

mmol/l

0.07

671

(1617658) Protocol used for examination of sentinel lymph nodes

146

0.68

0.52

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

508

1.17

0.52

2.0

2.4

174.48

177.69

0.10

486

(44816559) Phosphatidylethanol [Mass/volume] in Blood

399

1.18

0.49

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

301

1.20

0.45

2.3

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

103

1.36

0.45

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

103

1.36

0.45

2.8

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

330

0.82

0.45

2.4

3.1

28.43

24.13

mg/l

0.20

206

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.61

0.43

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.56

0.42

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

131

1.30

0.42

2.1

2.8

0.62

1.63

g/24h

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.41

0.0

3.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.47

0.40

3.6

5.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

2.6

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.40

0.0

2.6

—

30.66

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

353

1.16

0.39

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

106

0.66

0.39

3.9

3.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

279

1.19

0.38

1.1

1.3

—

(3022689) Creatine [Moles/volume] in Urine

1.39

0.38

1.0

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

112

1031

1.09

0.37

2.8

2.2

—

(3047189) Immunofixation for 24 hour Urine

1.35

0.37

1.0

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

523

0.88

0.36

1.2

1.1

—

(4035726) Immunohistochemistry procedure

113

1222

0.92

0.36

1.4

—

(40768806) Pleura Pathology biopsy report

0.62

0.35

1.2

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

118

1093

1.08

0.35

1.7

308.95

299.19

mu/l

0.11

110

982

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

348

1.15

0.35

1.4

1.2

—

(3036489) Thrombin time

614

1.11

0.34

1.8

2.0

20.32

21.06

0.79

513

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.67

0.32

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

132

0.76

0.32

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

138

1293

1.07

0.32

3.7

2.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

165

1.21

0.31

1.0

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

277

1.16

0.30

3.4

3.2

0.35

u/ml

0.02

147

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

526

0.89

0.30

8.8

10.2

23.82

24.22

mmol/l

0.32

514

(4146454) Self-monitoring of blood glucose

1.29

0.30

2.1

3.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

292

0.85

0.29

5.2

3.2

—

(40768800) Prostate Pathology biopsy report

110

0.73

0.28

1.0

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

395

3825

1.04

0.28

1.6

1.41

1.38

mmol/l

0.28

337

3314

(3042111) Morphology [Interpretation] in Bone marrow Narrative

173

0.81

0.28

2.2

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

118

0.76

0.27

1.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

1.28

0.26

2.3

3.2

0.20

0.31

e9/l

0.24

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

267

0.86

0.25

3.2

3.3

29.84

25.21

u/ml

0.11

259

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

820

1.08

0.25

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

912

0.93

0.25

2.1

1.7

3.97

4.45

mg/l

0.20

629

(3025130) Human papilloma virus identified in Specimen

382

0.89

0.25

2.1

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.27

0.24

3.2

3.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

134

1.20

0.23

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

134

1.20

0.23

1.0

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

134

1.20

0.23

1.7

1.6

—

(4281824) Cell count and differential, peritoneal fluid

157

0.83

0.22

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

458

1.09

0.22

1.6

1.5

72.44

120.83

pmol/l

0.94

449

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.19

0.21

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

9.22

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.21

0.0

2.7

—

259.09

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.4

—

12.40

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.6

—

23.49

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.20

0.0

1.1

—

15.39

—

(3017704) Immunofixation for Urine

1.25

0.20

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

538

1.08

0.20

4.0

3.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

148

1418

1.05

0.19

1.9

2.3

0.53

0.69

ug/l

2.67

723

(3011288) Drugs identified in Urine by Screen method

899

1.06

0.19

4.3

3.1

—

(3020650) Glucose [Presence] in Urine

1.18

0.19

2.8

1.4

—

(3016879) Cocaine [Presence] in Urine

130

1244

1.05

0.18

2.7

2.3

—

(3003694) ABO and Rh group [Type] in Blood

564

5738

0.98

0.18

1.6

1.7

—

(3027008) Opiates [Presence] in Urine

141

1354

1.04

0.17

2.5

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

140

1345

1.04

0.17

2.6

2.2

—

(3045788) Cell count panel - Pleural fluid

1.13

0.17

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.76

0.17

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

108

1032

1.05

0.17

1.5

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

886

1.05

0.16

1.4

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

350

1.09

0.16

1.1

—

(3028300) Cannabinoids [Presence] in Urine

141

1358

1.04

0.16

2.7

2.2

—

(3012441) Differential panel - Pleural fluid

1.10

0.15

1.1

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.77

0.15

42.7

37.0

6.85

7.67

ug/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

233

2269

1.03

0.15

1.9

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

313

1.09

0.15

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

142

1.13

0.12

1.3

1.2

—

(40768793) Breast Pathology biopsy report

425

1.06

0.11

1.2

1.3

—

(3002256) Pathology report gross observation

193

1973

0.98

0.10

1.2

—

(3027944) Amphetamines [Presence] in Urine

137

1335

1.03

0.10

2.7

2.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

503

0.95

0.09

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

165

0.91

0.09

2.3

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

288

0.94

0.08

1.1

2.89

1515.93

iu/ml

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.07

0.08

1.0

1.4

—

78.00

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

136

1.10

0.08

1.3

1.5

10.86

10.61

umol/l

0.06

127

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

226

0.93

0.08

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

0.79

0.08

2.0

5.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

234

1.07

0.08

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.83

0.07

1.0

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

174

0.92

0.07

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

0.80

0.07

2.7

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

204

0.93

0.07

3.2

2.4

6.75

7.11

mmol/l

0.34

196

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.12

0.07

1.0

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

129

1.09

0.05

1.2

1.3

0.04

1.17

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

283

0.95

0.05

1.7

2.7

128.92

100.67

ug/min

0.12

189

(3008037) Lactate [Moles/volume] in Venous blood

222

0.95

0.05

3.0

2.3

1.00

1.54

mmol/l

6.32

211

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

241

1.04

0.02

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

241

1.04

0.02

1.3

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

311

1.03

0.02

1.5

1.6

7.79

7.56

mmol/l

0.27

297

(3002523) Influenza virus A Ag [Presence] in Specimen

419

0.98

0.02

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

418

0.98

0.01

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

154

1.04

0.00

1.0

1.1

0.03

3.59

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

174

1.03

0.00

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

201

0.99

0.00

1.4

1.6

—

(3036180) Methadone [Presence] in Urine

127

1.02

0.00

2.5

2.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

133

0.98

0.00

1.2

1.3

1.67

1.29

promille

—

106

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

167

1.02

0.00

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.97

0.00

1.0

1.7

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

5.4

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.2

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.95

0.00

1.0

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.96

0.00

1.0

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.00

-0.00

1.0

1.8

—

(3051651) Icteric interference index of Serum or Plasma

0.99

-0.00

2.2

3.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3016228) CD19 cells/100 cells in Blood

1.00

-0.00

1.2

2.2

5.83

8.47

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.90

-0.00

1.3

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.96

-0.00

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

110

1.00

-0.00

2.5

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.00

-0.00

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

-0.00

0.0

2.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

10.0

—

(4212803) Bone marrow aspirate examination

0.00

-0.00

0.0

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

16.20

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.95

-0.00

1.4

1.5

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

179.78

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.1

—

476.78

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.99

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.00

-0.00

1.2

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SACROILIITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SACROILIITIS	1.026 [0.86, 1.22]	0.771
Birth year	1.0 [0.99, 1.01]	0.952

During the follow-up period (1.1.1998 — 31.12.2019), 189 out of 5262 females with M13_SACROILIITIS died.

Males

Parameter	HR [95% CI]	p-value
M13_SACROILIITIS	1.109 [0.93, 1.32]	0.239
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 161 out of 3252 males with M13_SACROILIITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SACROILIITIS.

N-year risk	Females	Males
1	0.093%	0.222%
5	0.627%	1.331%
10	1.608%	3.293%
15	3.278%	6.163%
20	5.972%	10.583%

Relationships between endpoints

↥

Index endpoint: M13_SACROILIITIS – Sacroiliitis, not elsewhere classified

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sacroiliitis, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints